These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 2085866)

  • 21. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event.
    Katz P; Zaytoun AM; Lee JH; Panush RS; Longley S
    J Immunol; 1982 Nov; 129(5):1966-71. PubMed ID: 7119439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
    Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
    Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Natural killer (NK) cells and interleukin 2 (IL-2) in Crohn disease].
    Lozano Polo JL; Echevarría Vierna S; Casafont Morencos F; Ledesma Castaño F; Pons Romero F
    Rev Esp Enferm Dig; 1990 Aug; 78(2):71-5. PubMed ID: 2271297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural killer cytolytic activity is associated with the expression of killer cell immunoglobulin-like receptors on peripheral lymphocytes in human.
    Kogure T; Mantani N; Sakai S; Shimada Y; Tamura J; Terasawa K
    Mediators Inflamm; 2003 Apr; 12(2):117-21. PubMed ID: 12775362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural killer cell activity of prostatic cancer patients.
    Choe BK; Frost P; Morrison MK; Rose NR
    Cancer Invest; 1987; 5(4):285-91. PubMed ID: 2444316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced natural killer cell activity in patients with pulmonary tuberculosis.
    Morikawa F; Nakano A; Nakano H; Oseko F; Morikawa S
    Jpn J Med; 1989; 28(3):316-22. PubMed ID: 2739140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 2 augmentation of the defective natural killer cell activity in patients with primary Sjögren's syndrome.
    Pedersen BK; Oxholm P; Manthorpe R; Andersen V
    Clin Exp Immunol; 1986 Jan; 63(1):1-7. PubMed ID: 3485480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of natural killer cell activity by macrophages in the rheumatoid joint and peripheral blood.
    Combe B; Pope R; Darnell B; Kincaid W; Talal N
    J Immunol; 1984 Aug; 133(2):709-13. PubMed ID: 6429243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of circulating immune complexes in pulmonary tuberculosis.
    Samuel AM; Ashtekar MD; Ganatra RD
    Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of NK cell activity in patients with oral maxillofacial squamous cell carcinoma].
    Wang JM
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1989 Mar; 24(2):101-3, 128. PubMed ID: 2512074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases.
    Shibatomi K; Ida H; Yamasaki S; Nakashima T; Origuchi T; Kawakami A; Migita K; Kawabe Y; Tsujihata M; Anderson P; Eguchi K
    Arthritis Rheum; 2001 Apr; 44(4):884-92. PubMed ID: 11315928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of interleukin 2 activity in patients with pulmonary tuberculosis].
    Xu SF
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Aug; 15(4):202-3, 253. PubMed ID: 1307511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NK cell activity in pulmonary tuberculosis.
    Yoneda T; Kasai M; Ishibashi J; Nishikawa K; Tokunaga T; Mikami R
    Br J Dis Chest; 1983 Apr; 77(2):185-8. PubMed ID: 6871086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced natural killer cell activity in multi-drug resistant pulmonary tuberculosis.
    Ratcliffe LT; Mackenzie CR; Lukey PT; Ress SR
    Scand J Immunol Suppl; 1992; 11():167-70. PubMed ID: 1514034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Natural killer cells in middle-aged and elderly tuberculosis patients].
    Adambekov DA
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):18-21. PubMed ID: 7778367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between natural killer cell activity and delayed-type hypersensitivity reaction to 2,4-dinitrochlorbenzene in the spectrum of chronic, intractable pulmonary tuberculosis.
    Yoneda T; Mikami R; Sakaguchi Y; Shirai F
    Tubercle; 1987 Mar; 68(1):59-64. PubMed ID: 3660462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of NK cell activity in patient with pulmonary tuberculosis].
    Shi R
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Dec; 13(6):363-4, 382. PubMed ID: 2085866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [NK cells in patients during complex therapy of destructive pulmonary tuberculosis].
    Gogebashvili NV; Nonikashvili MI
    Probl Tuberk; 1989; (4):43-5. PubMed ID: 2734264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [NK cell activity and counts of T-lymphocyte subsets in pulmonary tuberculosis].
    Qin J
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Aug; 13(4):209-11, 254. PubMed ID: 2151030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [NK cell activity in pulmonary tuberculosis (author's transl)].
    Yoneda T; Ishibashi J; Nishikawa K; Mikami R; Kasai M; Tokunaga T
    Kekkaku; 1982 Apr; 57(4):233-7. PubMed ID: 7109422
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.